Citation

89 FR 1925

Multiple canonical documents share this first-page citation.

Issuance of Priority Review Voucher; Rare Pediatric Disease Product Thursday, January 11, 2024 89 FR 1925
Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin; International Council for Harmonisation; Guidance for Industry; Availability Thursday, January 11, 2024 89 FR 1925